12/13/2024
3:34 PM | Janus Henderson Group (Filer)
Janus Henderson US Inc. (0002043380) (Filer)
| Form S-4/A | |
12/06/2024
12:47 PM | Benitec Biopharma Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
12/06/2024
10:36 AM | ARDELYX, INC. (Subject)
Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
12/06/2024
10:36 AM | Applied Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
12/06/2024
10:37 AM | Janus Henderson Group (Filed by)
Mereo BioPharma Group plc (Subject)
| Form SCHEDULE 13G/A | |
11/18/2024
3:34 PM | Janus Henderson Group (Filer)
Janus Henderson US Inc. (0002043380) (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/14/2024
2:13 PM | IDEAYA Biosciences, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
|
11/14/2024
2:15 PM | 4D Molecular Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:16 PM | CARGO Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:17 PM | AMDOCS LTD (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:19 PM | Janus Henderson Group (Filed by)
LIGAND PHARMACEUTICALS INC (Subject)
| Form SC 13G/A | |
11/14/2024
2:20 PM | BLACKBAUD INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:24 PM | Janus Henderson Group (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
1:55 PM | Janus Henderson Group (Filed by)
ZIFF DAVIS, INC. (Subject)
| Form SC 13G/A | |
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:05 PM | FLEX LTD. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:06 PM | Biohaven Ltd. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:08 PM | Janus Henderson Group (Filed by)
SS&C Technologies Holdings Inc (Subject)
| Form SC 13G/A | |
11/14/2024
2:09 PM | Janus Henderson Group (Filed by)
Sensata Technologies Holding plc (Subject)
| Form SC 13G/A | |
11/14/2024
2:11 PM | GLOBUS MEDICAL INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
1:53 PM | Janus Henderson Group (Filed by)
Vaxcyte, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
1:54 PM | Janus Henderson Group (Filed by)
OSI SYSTEMS INC (Subject)
| Form SC 13G/A | |
11/14/2024
11:28 AM | CytomX Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
11:30 AM | IMMUNIC, INC. (Subject)
IMMUNIC, INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
11:32 AM | Janus Henderson Group (Filed by)
Lexeo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
11:39 AM | Janus Henderson Group (Filed by)
TENAX THERAPEUTICS, INC. (Subject)
| Form SC 13G/A | |
11/14/2024
11:47 AM | 89bio, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:44 AM | Janus Henderson Group (Filed by)
Mereo BioPharma Group plc (Subject)
| Form SC 13G/A | |
11/14/2024
10:49 AM | Consensus Cloud Solutions, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:50 AM | AVADEL PHARMACEUTICALS PLC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:33 AM | Janus Henderson Group (Filed by)
TELEFLEX INC (Subject)
| Form SC 13G/A | |
11/14/2024
10:35 AM | CIMPRESS plc (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:36 AM | Janus Henderson Group (Filed by)
WEX Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
10:38 AM | ICU MEDICAL INC/DE (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:41 AM | Janus Henderson Group (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
10:27 AM | Beauty Health Co (Subject)
Beauty Health Co (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:10 AM | Janus Henderson Group (Filed by)
PepGen Inc. (Subject)
| Form SC 13G | |
11/14/2024
10:11 AM | Janus Henderson Group (Filed by)
Zai Lab Ltd (Subject)
| Form SC 13G | |
11/14/2024
9:44 AM | ASURE SOFTWARE INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:54 AM | Janus Henderson Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
11/14/2024
9:25 AM | EAGLE PHARMACEUTICALS, INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) It’s here. This is the moment we’ve been waiting for.
The next 3-6 months in crypto will be absolutely life-changing for those who are prepared.
Why? Because altcoin prices are about to explode. >> Register for the Workshop Now |
11/14/2024
9:26 AM | Janus Henderson Group (Filed by)
Structure Therapeutics Inc. (Subject)
| Form SC 13G | |
11/14/2024
9:28 AM | Dyne Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:29 AM | Aramark (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:31 AM | Caesars Entertainment, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:33 AM | Immunome Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:36 AM | Janus Henderson Group (Filed by)
NEOGENOMICS INC (Subject)
| Form SC 13G | |
11/14/2024
9:37 AM | Janus Henderson Group (Filed by)
REVVITY, INC. (Subject)
REVVITY, INC. (Subject)
| Form SC 13G | |
11/14/2024
9:39 AM | Janus Henderson Group (Filed by)
RENTOKIL INITIAL PLC /FI (Subject)
RENTOKIL INITIAL PLC /FI (Subject)
RENTOKIL INITIAL PLC /FI (Subject)
| Form SC 13G | |
11/14/2024
8:59 AM | ABEONA THERAPEUTICS INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
9:00 AM | Compass Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
9:02 AM | Janus Henderson Group (Filed by)
Skye Bioscience, Inc. (Subject)
Skye Bioscience, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
9:24 AM | Janus Henderson Group (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics, Inc. (Subject)
| Form SC 13G | |
11/14/2024
8:56 AM | Janus Henderson Group (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
8:50 AM | Catalent, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
8:53 AM | CONSTELLIUM SE (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
8:40 AM | Janus Henderson Group (Filed by)
Sarepta Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
6:46 AM | Janus Henderson Group (Subject)
Silchester International Investors LLP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:08 PM | CASSIDY WILLIAM B (Reporting)
Janus Henderson Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
3:41 PM | Janus Henderson Group (Issuer)
ROSENBERG MICHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
2:13 PM | Janus Henderson Group (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
2:26 PM | Benitec Biopharma Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/04/2024
1:17 PM | Janus Henderson Group (Subject)
ROSENBERG MICHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
1:19 PM | Benitec Biopharma Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
10/03/2024
8:55 AM | Janus Henderson Group (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13G | |
09/12/2024
6:46 PM | Janus Henderson Group (Issuer)
THOMPSON ROGER MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:44 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
4:09 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
9:43 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
6:41 PM | Janus Henderson Group (Filer)
| Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company | |
08/20/2024
5:24 PM | Janus Henderson Group (Issuer)
ROSENBERG MICHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
1:23 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
9:56 AM | Janus Henderson Group (Subject)
ROSENBERG MICHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
2:19 PM | Janus Henderson Group (Filed by)
TENAX THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
08/14/2024
9:48 AM | Janus Henderson Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/12/2024
8:06 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
2:30 PM | Consensus Cloud Solutions, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
08/09/2024
11:06 AM | Janus Henderson Group (Filed by)
WEX Inc. (Subject)
| Form SC 13G/A | |
08/05/2024
11:54 AM | Janus Henderson Group (Filed by)
Lexeo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
08/01/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
9:50 AM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
6:38 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
6:10 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2024
10:46 AM | Janus Henderson Group (Filed by)
Mereo BioPharma Group plc (Subject)
| Form SC 13G | |
07/10/2024
12:12 PM | Janus Henderson Group (Filed by)
Mirum Pharmaceuticals, Inc. (Subject)
| Form SC 13G | |
07/05/2024
4:20 PM | ARCA biopharma, Inc. (Subject)
ARCA biopharma, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
06/20/2024
4:22 PM | Janus Henderson Group (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/18/2024
10:37 AM | Dibadj Ali (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The #1 Coin for November 2024 (Ad) Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin…
And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone!
I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
 You can get access to the report by clicking here now… |
06/10/2024
3:17 PM | Akero Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
06/07/2024
2:01 PM | CRAWFORD BERG (Reporting)
Janus Henderson Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2024
4:04 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
2:06 PM | ABEONA THERAPEUTICS INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
05/07/2024
4:30 PM | DOLAN KEVIN B (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:24 PM | DOLAN KEVIN B (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | Janus Henderson Group (Issuer)
Quirk Alison A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Janus Henderson Group (Issuer)
Sheehan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
1:08 PM | Janus Henderson Group (Issuer)
SEYMOUR JACKSON ANGELA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free JHG Stock Alerts